Latest:
Impact of Clinical Trials on the Management of Multiple Myeloma
Continuing its discussion on clinical trials in multiple myeloma, the panel emphasizes the impact that data may have on the real-world treatment landscape.
Authors
Praveen Vikas, MBBS
Latest:
MRD and ctDNA Could Shift into Larger Role to Guide Treatment Decisions in Breast Cancer
Praveen Vikas, MBBS, discusses what is currently known regarding minimal residual disease testing in breast cancer, expanded on what still needs to be done to bring minimal residual disease and ctDNA testing to clinical practice, and highlighted the evolving treatment paradigm for patients with advanced hormone receptor-positive, HER2-negative breast cancer.
Estelamari Rodriguez, MD, MPH
Estelamari Rodriguez, MD, MPH, is associate director of Community Outreach – Thoracic Oncology at Sylvester Comprehensive Cancer Center.
Latest:
Lung Cancer Experts Highlight the Significance and Limitations of ADCs
Lung cancer experts discuss successes and hesitations regarding the evolving use of antibody-drug conjugates in non–small cell lung cancer.
Rona Yaeger, MD
Rona Yaeger, MD, is an associate attending physician, gastrointestinal medical oncologist, and early drug development specialist at the Memorial Sloan Kettering Cancer Center in New York.
Latest:
Dr Yaeger on the Efficacy of Adagrasib/Cetuximab in KRAS G12C+ mCRC
Rona Yaeger, MD, details the efficacy of adagrasib/cetuximab in heavily pretreated patients with KRAS G12C–mutant mCRC.
Rabi Upadhyay, MD
Rabi Upadhyay, MD, an instructor in the Department of Medicine at NYU Langone Health's Perlmutter Cancer Center
Latest:
Fellows on Film: What Makes a Good Mentor for an Oncology Fellow?
Michael L. Grossbard, MD, and Rabi Upadhyay, MD, Instructor, Department of Medicine at NYU Grossman School of Medicine, discuss the qualities that make someone a great mentor for an oncology fellow.
Jasmine M. Zain, MD
Latest:
Dr. Jasmine Zain: Challenges in T-Cell Lymphoma Treatment
Jasmine Zain, MD, director of the T-cell Lymphoma Program, professor of hematology and hematopoietic stem cell transplantation, of City of Hope National Medical Center, discusses the challenges of treatment for patients with T-cell lymphoma.